Download Oncology Nursing Drug Handbook - v3.5.13

There are quite a few APPS as good as MCQ Abubakr (ASU), X-RAY WOW, Jan Aushadhi Sugam (BPPI), Inject App, ALAT, Medical PG, FMGE Preparation - PrepLadder, and Oncology Nursing Drug Handbook - v3.5.13 too, one of the great APPS of the genre Medical.

Developed by Skyscape Medpresso Inc, Oncology Nursing Drug Handbook - v3.5.13 requires Android version at least Android 5.0+. Therefore you must update your phone if necessary.

Oncology Nursing Drug Handbook - v3.5.13 APK latest version is 3.5.13, release date 2020-06-25, and has size 8.4 MB.

Statistics about 1000 downloads are available from Google Play. You can update apps that have been downloaded or installed individually on your Android device if you want. Updating your apps gives you more. access to the latest features and improve the security and stability of the application.

Because not all games or apps are compatible for all phones. And the game or application is sometimes unavailable for your device, it depends on the Android OS version, screen resolutions or countries that Google Play allows access to. So at APK4Share you can easily download APK files and not be subject to these restrictions.

Written especially for nurses caring for patients with cancer, the 2020-2021 Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. This essential reference provides valuable information on effective symptom management, patient education, and chemotherapy administration.

DESCRIPTION
Completely revised and updated, the 2020-2021 Oncology Nursing Drug Handbook includes separate chapters on molecular and immunologic/biologic targeted therapies. These chapters provide fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer. It also offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for drugs recently approved by the FDA.

Key Features

- Provides valuable information on effective symptom management, patient education, and chemotherapy administration.
- Completely revised and updated, includes separate chapters on molecular and immunologic/biologic targeted therapies
- Provides fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer
- Offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for recently FDA approved drugs
- New drugs include: apalutamide (Erleada™), calaspargase pegol-mknl (Asparlas™), Daunorubicin and cytarabine liposome for injection (Vyxeos®), glucarpidase (Voraxaze®), alpelisib (Piqray®), binimetinib (Mektovi®), dacomitinib (Vizimpro®), Duvelisib (Copiktra®), encorafenib (Braftovi®), erdafitinib (Balversa™), lorlatinib (Lorbrena®), anakinra (Kineret®), baricitinib (Olumiant®), sarilumab (Kevzara®), aprepitant injectable emulsion (Cinvanti®), granisetron hydrochloride extended-release injection (Sustol®), letermovir (Prevymis™), omadacycline (Nuzyra™), meropenem/vaborbactam (Vabomere™), Plazomicin (Zemdri™), baloxavir marboxil (Xofluza™), imipenem/cilastatin sodium/relebactam (Recarbrio™), eravacycline (Xerava™), delafloxacin (Baxdela™)

Faster download with slow internet connectivity